ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,838Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 47

$678K Total Retail Price of All Prescriptions

Rank: 1 out of 47

805 Patients Receiving at Least One Drug in Part D
96%Patients 65 Years and Older
6% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Idaho
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

2% of this provider’s 805 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Risky Drugs to Seniors

0% of this provider’s 9,596 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$69 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

12 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Idaho
WARFARIN SODIUM 524 503 1 5
METOPROLOL SUCCINATE 523 506 2 4
METOPROLOL TARTRATE 438 423 3 7
AMLODIPINE BESYLATE 422 422 4 6
SIMVASTATIN 417 397 5 2
CLOPIDOGREL 356 336 6 10
CARVEDILOL 340 326 7 3
ATORVASTATIN CALCIUM 333 330 8 9
PRAVASTATIN SODIUM 319 316 9 17
HYDROCHLOROTHIAZIDE 304 300 10 18
PLAVIX 245 232 11 16
ZETIA 244 244 12 32
FUROSEMIDE 232 232 13 8
NITROSTAT 226 221 14 22
RAMIPRIL 224 206 15 25
LISINOPRIL 212 210 16 1
LOSARTAN POTASSIUM 179 175 17 12
DIGOXIN 159 151 18 11
PRADAXA 154 154 19 21
ATENOLOL 145 134 20 20
FLECAINIDE ACETATE 144 144 21 24
ISOSORBIDE MONONITRATE ER 130 126 22 15
ZOLPIDEM TARTRATE 122 122 23 55
OMEPRAZOLE 114 114 24 26
POTASSIUM CHLORIDE 107 107 25 13
LEVOTHYROXINE SODIUM 105 105 26 23
CRESTOR 101 101 27 19
EFFIENT 98 98 28 40
BYSTOLIC 92 88 29 37
VYTORIN 89 89 30 50
DIOVAN 82 82 31 30
NITROGLYCERIN PATCH 81 81 32 70
SPIRONOLACTONE 79 73 33 14
DILTIAZEM 24HR CD 78 74 34 31
RANEXA 76 73 35 59
AMIODARONE HCL 73 73 36 29
LIPITOR 68 68 37 46
DOXAZOSIN MESYLATE 64 64 38 65
ENALAPRIL MALEATE 64 64 38 39
ALLOPURINOL 60 60 40 47
BENICAR 60 60 40 76
LOVASTATIN 53 53 42 45
QUINAPRIL HCL 53 51 42 41
DILTIAZEM 24HR ER 53 50 42 48
AMLODIPINE BESYLATE-BENAZEPRIL 53 53 42 82
BENICAR HCT 52 52 46 83
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 4, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.